Use of the Monoclonal Antibody Regdanvimab to Treat Patients Hospitalized with COVID-19: Real-World Data during the Delta Variant Predominance
使用单克隆抗体Regdanvimab治疗COVID-19住院患者：Delta变异株占主导地位期间的真实世界数据
期刊:Infection and Chemotherapy
影响因子:2.9
doi:10.3947/ic.2022.0103
Kwak, Yee Gyung; Song, Je Eun; Kang, Jieun; Kang, Jiyeon; Kang, Hyung Koo; Koo, Hyeon-Kyoung; Park, Hye Kyeong; Choi, Sang Bong; Lee, Hyuk Pyo; Lee, Myung Jin; Kim, Baek-Nam
